NHTSA Report: Alcohol and Drug Prevalence Among Seriously or Fatally Injured Road Users
About this document
- Layer
- attachment: a document a meeting packet links to
- Type as titled
- publication (kind from doc_type)
- File
- 3a0160e9792366039c4c24908c2d7e1cb47c0353 application/pdf
- Cases
About: Jaime Bermudez (case)
passengers, 43.1% of bicyclists, and 61.0% of other (e.g., moped, ATV, electric kick scooter; unknown position) roadway users presenting to the trauma centers tested positive for one or more drugs included on the study's drug panel. Drug category positivity does appear to vary somewhat by position in crash. For drivers, the most prevalent drug category was cannabinoids (active THC) at 25.0%, followed by alcohol at 21.6%, and stimulants at 9.8%. Additionally, 18.1% of the total trauma center driver cases tested positive for two or more categories of drugs. Pedestrians showed a somewhat different pattern with alcohol being the most prevalent at 24.7%, followed by cannabinoids at 21.5%, and stimulants at 13.7%. For pedestrians, 20.1% tested positive for two or more categories. The other positions in crash also showed variations in drug category prevalence.
Table 9 includes drug prevalence results by position in crash for ME cases. Overall, 68.8% of drivers, 68.6% of pedestrians, 64.2% of passengers, 56.5% of bicyclists, and 52.9% of other roadway users presenting to the MEs tested positive for one or more drugs included on the study's panel. For drivers presenting to the MEs, alcohol was the most prevalent at 38.9%, followed by cannabinoids at 31.7%, and opioids at 13.0%. Additionally, 33.9% of the ME driver cases tested positive for two or more categories of drugs. Pedestrians presenting to the MEs showed a slightly different pattern with alcohol being the most prevalent at 35.7%, followed by opioids at 22.2%, and cannabinoids at 17.4%. ME pedestrian cases tested positive for two or more categories of drugs 33.8% of the time. The other positions in crash also showed variations in drug category prevalence, but the sample sizes were small for these categories of road users for the ME cases.
Additional tables in Appendix A provide trauma center and ME results broken out for each study site and position in crash. Comparisons across sites should be made with caution for a number of factors including differences in study start dates at each site and total number of cases collected at each.
The remainder of this report focuses on results for drivers only because of the known potentially impairing effects of the studied drugs on motor vehicle operators. Results are combined across study sites for the entire study period to provide an examination of drug prevalence among a large sample of drivers. Any statistical analyses presented should be interpreted with caution as they are intended to only examine potential associations of drug positivity with other variables of interest for the trauma center and ME cases separately. No statistical inferences should be made beyond this study's sample and participating sites given the site selection approach and overall study design.
25
Keys: ← → or j k turn pages; / finds.